Health Care & Life Sciences » Pharmaceuticals | Pernix Therapeutics Holdings Inc.

Pernix Therapeutics Holdings Inc.

Pernix Therapeutics Holdings Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
13.92 M
Public Float
11.76 M
Pernix Therapeutics Holdings Inc.
Stock Exchange NASDAQ Stock Market
EPS
$5.06
Market Cap
$13.04 M
Shares Outstanding
13.92 M
Public Float
13.48 M

Profile

Address
10 North Park Place
Morristown New Jersey 07960
United States
Employees -
Website http://www.pernixtx.com
Updated 09/14/2018
Pernix Therapeutics Holdings, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It focuses on therapeutics for diseases on central nervous system, neurology, pain, and psychiatry. Its products include treatment of migraine pain and inflammation, insomnia, and depressive disorder.

Financials

View All

John A. Sedor
Chairman & Chief Executive Officer
John R. Leone
Lead Independent Director